stopOverflowHandler

Life sciences

Patents are now an essential part of the development of new products in Life Sciences. IP Overview helps you to better understand the competitive landscape in your field, to better understand the trends and analyse the maturity of an emerging market. 



Order by:
€1 345.50 (including 19.6 % tax)

CDK Inhibitors patent landscape - 2009/10

One of the most exciting developments in the 90’s has been the elucidation of the molecular mechanisms that control the progression of cells through the division cycle. The cell-cycle progression is composed of two main phases, interphase and mitosis. It is controlled by a set of kinases in which cyclin dependent kinases (CDK) play a major role in triggering the cell cycle transitions.  
Product Details...



€1 943.50 (including 19.6 % tax)

HIV Therapy patent landscape - 2009/04

Discovered in 1983, the HIV virus has been the subject of intensive research and development within the academic and industrial sectors... 
Product Details...



€1 495.00 (including 19.6 % tax)

Malaria patent landscape - 2009/07

With 300 to 500 million people suffering from Malaria, 1 to 3 million deaths every year and half of the world population at risk, malaria is the third most deadly infectious disease. 
Product Details...




  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»
Results 1 - 3 of 3
 
 

Identification